Ojeda Soledad, Romaguera Rafael, Cruz-González Ignacio, Moreno Raúl
Servicio de Cardiología, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica (IMIBIC), Universidad de Córdoba, Córdoba, España.
Servicio de Cardiología, Hospital de Bellvitge, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, España.
Rev Esp Cardiol. 2020 Nov;73(11):927-936. doi: 10.1016/j.recesp.2020.07.024. Epub 2020 Sep 28.
The Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) presents its annual report on the activity for 2019.
All Spanish centers with a catheterization laboratory were invited to participate. Data were introduced online and analyzed by an external company together with the Steering Committee of the ACI-SEC.
A total of 119 centers participated (83 public, 36 private). In all, there were 165 124 diagnostic studies (4.7% more than in 2018). The use of pressure wire and intravascular ultrasound increased by 20% and that of optical coherence tomography by 8.4%. The number of percutaneous coronary interventions (PCI) rose by 4.5% (75 819 procedures). Of these, 22 529 were performed in the acute myocardial infarction setting, with 91.8% being primary PCI (6.3% increase). The mean number of primary PCIs per million inhabitants increased to 439. Among PCIs, access was radial in 88.3%. There were 4281 transcatheter aortic valve implantations (21.0% increase), with an average of 90.9 per million inhabitants. Mitral valve repair also rose by 17.4% (n = 385), left atrial appendage closure by 43.0% (n = 921) and patent foramen ovale closure by 38.1% (n = 710).
In 2019, the use of intracoronary diagnostic techniques increased, as did that of diagnostic and therapeutic coronary procedures, mainly in primary PCI. Of particular note was the marked increase in the number of transcatheter aortic valve implantations, as well as in the number of mitral valve repairs and left atrial appendage and patent foramen ovale closure procedures.
西班牙心脏病学会介入心脏病学协会(ACI - SEC)发布其2019年年度活动报告。
邀请了所有设有心导管实验室的西班牙中心参与。数据通过在线录入,并由一家外部公司与ACI - SEC指导委员会共同进行分析。
共有119个中心参与(83个公立,36个私立)。总计有165124项诊断研究(比2018年增加4.7%)。压力导丝和血管内超声的使用增加了20%,光学相干断层扫描的使用增加了8.4%。经皮冠状动脉介入治疗(PCI)的数量增加了4.5%(75819例手术)。其中,22529例在急性心肌梗死情况下进行,91.8%为直接PCI(增加6.3%)。每百万居民直接PCI的平均数量增至439例。在PCI中,88.3%采用桡动脉入路。有4281例经导管主动脉瓣植入术(增加21.0%),每百万居民平均90.9例。二尖瓣修复也增加了17.4%(n = 385),左心耳封堵增加了43.0%(n = 921),卵圆孔未闭封堵增加了38.1%(n = 710)。
2019年,冠状动脉内诊断技术的使用有所增加,诊断和治疗性冠状动脉手术的使用也是如此,主要是在直接PCI方面。特别值得注意的是,经导管主动脉瓣植入术的数量显著增加,以及二尖瓣修复、左心耳和卵圆孔未闭封堵手术的数量增加。